CSB Bancorp, Inc. (CSBB) stock analysis
Close on Oct 19, 2026Market cap –P/E 14.8Yield 2.19%
StockData Score
Prices as of Nov 11, 2026How the score works
Weak8 of 30 checks passed
CSB Bancorp passes 8 of the 30 checks behind our score; 16 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 0/6
- Growth
- 2/6
- Past performance
- 3/6
- Financial health
- 3/6
- Dividend
- 0/6
What stands out
Earnings grew over 5 years
Net income grew 4.8% a year on average over the last five fiscal years.
Earnings growth accelerating
Net income grew 18.7% over the last twelve months, against a 5-year average of 4.8% a year.
Well capitalized
Equity is 10.2% of total assets; 8% or more is a comfortable cushion.
Growing faster than the industry
Revenue grew 16.3% over the last twelve months; the Commercial Banks median is 11.3%.
What to watch
Return on equity under 15%
Return on equity was 12.0% over the last twelve months and averaged 11.9% over five years; we look for 15% on both.
Revenue growing under 10% a year
Revenue grew 8.4% a year over the last three fiscal years, short of the 10% we look for.
EPS growing under 10% a year
Diluted EPS grew 1.1% a year over the last three fiscal years.
Net margin below its 5-year average
Net margin was 28.5% over the last twelve months, against a 5-year average of 29.9%.
Valuation0/6
P/E against its history
Not enough price and earnings history to compare.
P/E against the industry
Needs positive earnings and enough profitable companies in the industry.
P/S against the industry
Not enough revenue data to compare.
P/B against the industry
Needs positive book value.
Price against fair value
We could not estimate a fair value: it needs at least two valuation methods with positive inputs.
Margin of safety
Depends on the fair value estimate.
Growth2/6
Revenue growing under 10% a year
Revenue grew 8.4% a year over the last three fiscal years, short of the 10% we look for.
EPS growing under 10% a year
Diluted EPS grew 1.1% a year over the last three fiscal years.
Earnings growth accelerating
Net income grew 18.7% over the last twelve months, against a 5-year average of 4.8% a year.
Growing faster than the industry
Revenue grew 16.3% over the last twelve months; the Commercial Banks median is 11.3%.
Company guidance
No outlook found in earnings releases from the last twelve months.
Gross margin trend
Banks and insurers do not report gross profit.
Past performance3/6
Return on equity under 15%
Return on equity was 12.0% over the last twelve months and averaged 11.9% over five years; we look for 15% on both.
Return on assets over 1%
Return on assets was 1.2%; for a bank or insurer, 1% or more is considered good.
Return on equity above the industry
CSB Bancorp's return on equity of 12.0% is above the Commercial Banks median of 11.5%.
Earnings grew over 5 years
Net income grew 4.8% a year on average over the last five fiscal years.
Net margin below its 5-year average
Net margin was 28.5% over the last twelve months, against a 5-year average of 29.9%.
Net margin below the industry
CSB Bancorp's net margin of 28.5% is below the Commercial Banks median of 30.3%.
Financial health3/6
Well capitalized
Equity is 10.2% of total assets; 8% or more is a comfortable cushion.
Loans funded by deposits
Needs loans and deposits.
Adequate loan-loss reserve
The allowance for credit losses is not reported.
Efficient operations
Non-interest expense takes 54.4% of revenue; under 60% is efficient for a bank.
Deposits growing
Deposits grew 4.0% over the past year.
Borrowings
Needs debt and equity figures.
Dividend0/6
No dividend
CSB Bancorp has not paid a dividend in the last twelve months.
Yield against Treasuries
No dividend.
Yield against the market
No dividend.
Dividend stability
No dividend.
Earnings cover
No dividend.
Cash-flow cover
No dividend.
Fair value
How we estimate itWe don't publish a fair value for CSB Bancorp. It needs a US-dollar share price, at least two valuation methods with positive inputs (earnings, EBITDA, book value or sales) and, for companies with several share classes, classes that trade at the same price.
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Own 5-year median 8.8
- Commercial Banks median 12.1
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Margins
Share of revenue, fiscal years 2011 to 2025
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +13.0% | +8.4% | +7.2% | +7.2% | |
| Net income | +33.5% | +0.1% | +4.8% | +8.3% | |
| EPS, diluted | +34.8% | +1.1% | +5.7% | +8.7% | |
| Free cash flow | +39.2% | +10.8% | +9.4% | +10.5% | |
| Dividend per share | +3.8% | +8.1% | +7.7% | +8.0% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 10.6% | 11.8% | 11.1% | |
| Return on assets | 1.0% | 1.1% | 1.1% | |
| Capex to revenue | 5.4% | 5.7% | 0.8% | |
| Diluted shares | 3M | 3M | 3M |
Where the cash went
Fiscal 2021 to 2025, five years combined
CSB Bancorp generated $80.19M from operations and spent $29.06M on capital expenditure, dividends and share buybacks. 18% of that went back into the business.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 26.9% | 0.04× | 10.30× | 11.1% |
| FY2024 | 22.8% | 0.04× | 10.64× | 9.0% |
| FY2023 | 34.4% | 0.04× | 11.47× | 14.5% |
| FY2022 | 34.1% | 0.03× | 11.92× | 13.8% |
| FY2021 | 31.1% | 0.03× | 11.38× | 11.3% |
| FY2020 | 30.1% | 0.04× | 10.32× | 11.8% |
| FY2019 | 30.8% | 0.04× | 9.57× | 12.9% |
| FY2018 | 29.9% | 0.04× | 9.78× | 12.8% |
| FY2017 | 24.7% | 0.04× | 10.13× | 10.4% |
| FY2016 | 25.5% | 0.04× | 10.42× | 10.6% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero$13.36M
- Cash generatingOperating cash flow above zero$19.50M
- Return on assets improvedROA up on the prior year0.8% → 1.1%
- Earnings backed by cashOperating cash flow above net income$19.50M vs $13.36M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose– → –
- No dilutionShare count did not rise3M → 3M
- Gross margin improvedGross margin up on the prior year– → –
- More efficientAsset turnover rose0.04 → 0.04
See a number that looks wrong?